ARCAM PHARMACEUTICAL CORP. v. Faria

513 F.3d 1, 2007 U.S. App. LEXIS 29731, 2007 WL 4508595
CourtCourt of Appeals for the First Circuit
DecidedDecember 26, 2007
Docket07-1046
StatusPublished
Cited by31 cases

This text of 513 F.3d 1 (ARCAM PHARMACEUTICAL CORP. v. Faria) is published on Counsel Stack Legal Research, covering Court of Appeals for the First Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
ARCAM PHARMACEUTICAL CORP. v. Faria, 513 F.3d 1, 2007 U.S. App. LEXIS 29731, 2007 WL 4508595 (1st Cir. 2007).

Opinion

SMITH, District Judge.

When this case was last before us, we stated unequivocally that the Complaint in this matter failed to state any viable constitutional claims. Pagán v. Calderón, 448 F.3d 16, 37 (1st Cir.2006). Given the holding in Pagan, dismissal on remand by the District Court of appellant ARCAM Pharmaceutical Corporation’s (“ARCAM”) claims was inevitable. Nevertheless, AR-CAM now appeals the dismissal of its suit against appellees Antonio Faria and Vilma Pellot. ARCAM argues that the Pagdn decision was not binding on its claims against Faria and Pellot, and that the District Court erred in extending Pagdn to dismiss the claims against these Defendants. After reviewing ARCAM’s arguments and the record, we affirm the District Court’s dismissal of the suit.

The facts giving rise to the Complaint fully were set forth by this Court in Pa-gdn, and need not be repeated in detail here. See Pagán, 448 F.3d at 23-26. To summarize, briefly, “[t]he underlying action involves multiple plaintiffs and multiple defendants ... The plaintiffs’ overarching claim is that Calderón, then the governor of Puerto Rico, improperly influenced the decision of a government lender to reject a loan sought by the main plaintiff, ARCAM.” Id. at 23. All that is necessary for purposes of this appeal is as follows: Appellees Faria and Pellot were President and a “high ranking” official, respectively, of the Banco de Desarrollo Económico para Puerto Rico (“BDE”), the lender which denied ARCAM its sought after commercial loan for $5,000,000. Plaintiffs alleged that Faria and Pellot were the vehicles through which Calderón exerted undue influence over BDE’s directors in order to prevent BDE from granting ARCAM’s loan request.

After this Court’s decision in Pagdn, the remaining claims of the underlying Complaint, if alive at all, were on life support. In Pagán, we had before us Calderon’s appeal of the District Court’s denial of her motion to dismiss all claims against her on the grounds of qualified immunity. We first took up the issue of justiciability, and concluded that only ARCAM had standing to pursue its claims against Defendants. We therefore dismissed the claims of all other Plaintiffs. With all Plaintiffs except ARCAM out of the picture, and only AR-CAM’s equal protection and substantive due process claims remaining, we turned to Calderon’s claim of qualified immunity. Id. at 23. Applying the usual qualified immunity rubric, see, e.g., Limone v. Condon, 372 F.3d 39, 44 (1st Cir.2004), we conclusively found that ARCAM “failed adequately to plead a violation of its constitutional rights,” directed the District Court to grant Calderon’s motion for dismissal of all claims against her, and remanded for further consistent proceedings. 1 Pagán, 448 F.3d at 23.

On remand, the District Court quite predictably ordered the parties to show cause why the remaining claims should not be dismissed based on the holding of Pagdn. After considering the parties’ submissions, the Court then incor *3 porated in toto this Court’s analysis in Pagan, and disposed of all further pending matters, including supplemental claims raised under Puerto Rican law. 2 Now before us is ARCAM’s last-gasp appeal of the District Court’s dismissal of its remaining claims against Pellot and Faria. ARCAM stands on shaky ground when it claims that this Court’s analysis in Pagan was little more than dicta as to Pellot and Faria. We have held that “when a statement in a judicial decision is essential to the result reached in the case, it becomes part of the court’s holding.” Rossiter v. Potter, 357 F.3d 26, 31 (1st Cir.2004). The result, along with those portions of the opinion necessary to the result, are binding, whereas dicta is not. Id. “Dictum constitutes neither the law of the ease nor the stuff of binding precedent,” Dedham Water Co. v. Cumberland Farms Dairy, Inc., 972 F.2d 453, 459 (1st Cir.1992); rather, it “comprises observations in a judicial opinion or order that are ‘not essential’ to the determination of the legal questions then before the court.” Municipality of San Juan v. Rullán, 318 F.3d 26, 29 n. 3 (1st Cir.2003) (quoting Dedham Water Co., 972 F.2d at 459); see also Pierre N. Leval, Judging Under the Constitution: Dicta About Dicta, 81 N.Y.U. L. Rev. 1249, 1256 (2006) (Dictum is superfluous content — “an assertion in a court’s opinion of a proposition of law which does not explain why the court’s judgment goes in favor of the winner”).

Because Calderón was the sole appellant in Pagan, our reversal of the District Court’s refusal to dismiss ARCAM’s equal protection and substantive due process claims technically related only to those allegations aimed at Calderón. However, the holding was premised on the essential finding that ARCAM’s allegations “do not state viable constitutional claims,” a determination that was by no means uniquely applicable to Calderón, but instead spoke broadly to the failings of the Complaint as a whole. Pagán, 448 F.3d at 37.

As to ARCAM’s specific allegation that Calderón transgressed its substantive due process rights when, through Pellot and Faria, she exerted undue influence over BDE’s directors so that they would deny ARCAM’s loan request, we concluded that “the mere withholding of the loan, simplicitor, cannot support a constitutional claim.” Id. at 33. This conclusion required dismissal of ARCAM’s substantive due process claim, was not dicta, and applies with equal force to the identical claims alleged against Pellot and Faria. We were similarly forthright with regard to ARCAM’s equal protection claim: “... [the claim] does not pass constitutional muster.” Id. at 35. Here, the analysis was two-pronged: first, ARCAM failed to plead facts establishing that a similarly situated borrower was treated differently than it; and second, the Complaint offered no allegations indicating that the disparate treatment of which ARCAM complains resulted from a gross abuse of power, invidious discrimination, or fundamentally unfair procedures. 3 These flaws doomed AR- *4 CAM’s equal protection claims against all remaining Defendants, not just Calderón.

Though our holding in Pagan was limited to Calderon’s appeal, it cannot, as AR-CAM urges, reasonably be read in isolation from the case as a whole. Rather, as set forth above, the core holding of Pagan

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Untitled Case
D. New Hampshire, 2026
Marcia Stein v. Kaiser Foundation Health Plan, Inc.
115 F.4th 1244 (Ninth Circuit, 2024)
Rosa v. Garland
114 F.4th 1 (First Circuit, 2024)
WESTERN HEIGHTS INDEPENDENT SCHOOL DISTRICT v. STATE
2022 OK 79 (Supreme Court of Oklahoma, 2022)
Markham Concepts v. Hasbro
1 F.4th 74 (First Circuit, 2021)
Bien v. City of Fresno
E.D. California, 2021
(HC) Arguello v. Muniz
E.D. California, 2020
United States v. Ruff
Second Circuit, 2019
Christy, Inc. v. United States
Federal Claims, 2019
United States v. Chin
913 F.3d 251 (First Circuit, 2019)
Kando v. Rhode Island State Board of Elections
880 F.3d 53 (First Circuit, 2018)
United States v. Starks, Jr.
861 F.3d 306 (First Circuit, 2017)
Igartúa v. Obama
842 F.3d 149 (First Circuit, 2016)
In re: Off Dock USA, Inc.
Ninth Circuit, 2015
In Re GRAND JURY PROCEEDINGS
744 F.3d 211 (First Circuit, 2014)

Cite This Page — Counsel Stack

Bluebook (online)
513 F.3d 1, 2007 U.S. App. LEXIS 29731, 2007 WL 4508595, Counsel Stack Legal Research, https://law.counselstack.com/opinion/arcam-pharmaceutical-corp-v-faria-ca1-2007.